McGill University Health Centre, Glen Site, Montreal Children's Hospital
Montreal
0 studies enrolling now · 6 studies all time
What they study most
Cystic Fibrosis
Studies at this site
- A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
- Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF) — Completed
- A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
- Long-term Safety of Lumacaftor/Ivacaftor in Participants With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation — Completed
- A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation — Completed
- Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del — Completed